Bernstein, Robert J. – Trademark Portfolio
Entity Type: 01
Bernstein, Robert J. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 10 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UNIQUELY NORMAL, THE PARENT COMPANY, and UNIQUELY NORMAL CENTER FOR AUTISM. The owner is based in New York, NY.
17th Floor
380 Lexington Avenue
New York, NY 10168
Showing of trademarks Trademarks
Trademark Classifications
Bernstein, Robert J.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Bernstein, Robert J. have?
Bernstein, Robert J. has 14 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned, 5 cancelled.
What trademark classes does Bernstein, Robert J. file in?
Bernstein, Robert J. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Bernstein, Robert J.'s most well-known trademarks?
Bernstein, Robert J.'s registered trademark portfolio includes well-known marks such as UNIQUELY NORMAL, THE PARENT COMPANY, and UNIQUELY NORMAL CENTER FOR AUTISM. These are among 3 currently registered trademarks in the portfolio.
What is Bernstein, Robert J.'s trademark registration success rate?
Bernstein, Robert J. has a 21% trademark registration rate, with 3 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.